NVS: Novartis AG Stocks News on July 17, 2025

NVS

Investing.com

a day ago

Novartis fails to block MSN from selling generic heart drug Entresto

Thermo Fisher acquires Sanofi's New Jersey manufacturing site

NVS

Reuters

a day ago

Thermo Fisher acquires Sanofi's New Jersey manufacturing site

Trump threatens tariffs on medicines within weeks

NVS

The Telegraph

a day ago

Trump threatens tariffs on medicines within weeks

Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.

NVS

Barrons.com

a day ago

Trump Threatens Pharma Tariffs This Month. Why the Stocks Are Looking Healthy.

3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS

NVS

Zacks

2 days ago

3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS

Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?

NVS

Zacks

2 days ago

Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?

Inflation Data and Bank Earnings Kick Off a Crucial Test for Markets

NVS

The Daily Upside

2 days ago

Inflation Data and Bank Earnings Kick Off a Crucial Test for Markets

Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure

NVS

Zacks

3 days ago

Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure

Exploring Analyst Estimates for Novartis (NVS) Q2 Earnings, Beyond Revenue and EPS

NVS

Zacks

3 days ago

Exploring Analyst Estimates for Novartis (NVS) Q2 Earnings, Beyond Revenue and EPS

Novartis AG (VTX:NOVN) On An Uptrend: Could Fundamentals Be Driving The Stock?

NVS

Simply Wall St.

3 days ago

Novartis AG (VTX:NOVN) On An Uptrend: Could Fundamentals Be Driving The Stock?

What To Expect in Markets This Week: Big Bank Earnings, June Inflation, Retail Sales Data

NVS

Investopedia

4 days ago

What To Expect in Markets This Week: Big Bank Earnings, June Inflation, Retail Sales Data

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports

NVS

TipRanks

5 days ago

FDA willing to trade faster drug reviews for lower prices, Bloomberg reports

Portfolio manager sees long-term AI upside in healthcare sector

NVS

Reuters Videos

6 days ago

Portfolio manager sees long-term AI upside in healthcare sector

NVS

MT Newswires

6 days ago

Sector Update: Health Care Stocks Retreat Late Afternoon

NVS

MT Newswires

6 days ago

Novartis Loses Patent Infringement Suit Against MSN Pharmaceuticals for Entresto Generic

NVS

MT Newswires

6 days ago

Market Chatter: FDA May Fast Track Drug Reviews for Lower US Prices

Bayer Wins Hormone-Free Treatment Approval for Women in the UK

NVS

Zacks

6 days ago

Bayer Wins Hormone-Free Treatment Approval for Women in the UK

Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS)

NVS

CNW Group

7 days ago

Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS)

Alcohol Related Liver Disease Market Forecast, 2025-2035 | Personalized Medicine Transforming ARLD Treatment Landscape

NVS

GlobeNewswire

7 days ago

Alcohol Related Liver Disease Market Forecast, 2025-2035 | Personalized Medicine Transforming ARLD Treatment Landscape

Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump

NVS

Zacks

7 days ago

Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump

Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding

NVS

BioPharma Dive

7 days ago

Renasant Bio, chasing drugs for ADPKD, raises $55M in seed funding

$14 Billion Cell and Gene Therapy Market to Double by 2030, Driven by Oncology and RNA Breakthroughs, reports Kalorama Information

NVS

PR Newswire

8 days ago

$14 Billion Cell and Gene Therapy Market to Double by 2030, Driven by Oncology and RNA Breakthroughs, reports Kalorama Information

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

NVS

PR Newswire

8 days ago

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

Trump's Drug Tariffs: Where Does the U.S. Import Pharmaceuticals From?

NVS

The Wall Street Journal

8 days ago

Trump's Drug Tariffs: Where Does the U.S. Import Pharmaceuticals From?

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

NVS

Pharma Voice

8 days ago

As its cancer vaccine moves through the clinic, Transgene sets sights on manufacturing

NVS

MT Newswires

9 days ago

Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs

Finally: A malaria drug made just for babies has been approved—here’s why it matters

NVS

FastCompany

9 days ago

Finally: A malaria drug made just for babies has been approved—here’s why it matters

Ascentage Pharma Names CFO & SVP of Global Corporate Development & Finance

NVS

Exec Edge

9 days ago

Ascentage Pharma Names CFO & SVP of Global Corporate Development & Finance

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

Zacks

9 days ago

Why Novartis (NVS) is a Top Value Stock for the Long-Term

NVS

MT Newswires

9 days ago

Novartis Gets Swiss Approval for Malaria Drug for Infants

Swissmedic approves Novartis’ malaria medicine for babies

NVS

Pharmaceutical Technology

9 days ago

Swissmedic approves Novartis’ malaria medicine for babies

Novartis receives approval for first malaria medicine for newborn babies and young infants

NVS

GlobeNewswire

9 days ago

Novartis receives approval for first malaria medicine for newborn babies and young infants

NVS

MT Newswires

10 days ago

Sector Update: Health Care

Here's Why Novartis (NVS) is a Strong Momentum Stock

NVS

Zacks

10 days ago

Here's Why Novartis (NVS) is a Strong Momentum Stock

Novartis’ Cosentyx shows no benefit in Phase III GCA trial

NVS

Clinical Trials Arena

13 days ago

Novartis’ Cosentyx shows no benefit in Phase III GCA trial

Switzerland seeks trade deal with Trump without getting into EU bind

NVS

Reuters

14 days ago

Switzerland seeks trade deal with Trump without getting into EU bind

Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study

NVS

Zacks

14 days ago

Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study

FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug

NVS

Zacks

14 days ago

FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug

Business and Investment Opportunities in Nuclear Medicine 2025-2030: North America Leads, Asia-Pacific Races

NVS

GlobeNewswire

14 days ago

Business and Investment Opportunities in Nuclear Medicine 2025-2030: North America Leads, Asia-Pacific Races

NVS

MT Newswires

14 days ago

Novartis Says Cosentyx Fails to Meet Primary Endpoint in Phase 3 Giant Cell Arteritis Study

Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)

NVS

PR Newswire

14 days ago

Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)

Actinium Highlights ATNM 400 Progress at SNMMI Conference

NVS

Insider Monkey

14 days ago

Actinium Highlights ATNM 400 Progress at SNMMI Conference

Buy These 5 Low-Leverage Stocks Amid Wall Street's Tricky July Start

NVS

Zacks

15 days ago

Buy These 5 Low-Leverage Stocks Amid Wall Street's Tricky July Start

What's Fueling Tempus AI's Explosive Sales Growth?

NVS

Zacks

15 days ago

What's Fueling Tempus AI's Explosive Sales Growth?

Can China sustain a surge in oncology drug innovation?

NVS

Pharma Voice

15 days ago

Can China sustain a surge in oncology drug innovation?

Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?

NVS

Zacks

16 days ago

Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?

Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run?

NVS

Zacks

16 days ago

Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run?

Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion

NVS

Insider Monkey

19 days ago

Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

NVS

Zacks

20 days ago

Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?

Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?

NVS

Investor's Business Daily

21 days ago

Incyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?

Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes

NVS

Investor's Business Daily

21 days ago

Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes

Incyte replaces CEO Hoppenot with dealmaker Meury

NVS

BioPharma Dive

21 days ago

Incyte replaces CEO Hoppenot with dealmaker Meury

Kashiv BioSciences reports positive results from trial of Xolair biosimilar

NVS

Clinical Trials Arena

21 days ago

Kashiv BioSciences reports positive results from trial of Xolair biosimilar

ProFound Therapeutics Announces Multi-Year Strategic Collaboration with Novartis to Discover and Develop Novel Therapeutics for Cardiovascular Disease

NVS

GlobeNewswire

21 days ago

ProFound Therapeutics Announces Multi-Year Strategic Collaboration with Novartis to Discover and Develop Novel Therapeutics for Cardiovascular Disease

Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements

NVS

GlobeNewswire

21 days ago

Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements

NVS

Pharmaceutical Technology

21 days ago

Novartis concludes Regulus Therapeutics acquisition

Can Biogen Save Even More Kids With This New Drug?

NVS

Investor's Business Daily

22 days ago

Can Biogen Save Even More Kids With This New Drug?

Novartis completes acquisition of Regulus Therapeutics

NVS

GlobeNewswire

22 days ago

Novartis completes acquisition of Regulus Therapeutics

Can Biogen Outdo Its Own Spinal Muscular Atrophy Drug?

NVS

Investor's Business Daily

22 days ago

Can Biogen Outdo Its Own Spinal Muscular Atrophy Drug?

NVS

MT Newswires

22 days ago

Alvotech Says Proposed Xolair Biosimilar Study Meets Primary Endpoint

Novartis announces expiration of Regulus Therapeutics tender offer

NVS

GlobeNewswire

22 days ago

Novartis announces expiration of Regulus Therapeutics tender offer

NVS

Insider Monkey

23 days ago

Novartis AG (NVS): A Bull Case Theory

Top Analyst Reports for JPMorgan, Novartis & AT&T

NVS

Zacks

23 days ago

Top Analyst Reports for JPMorgan, Novartis & AT&T

Brain Cancer Market Research Report 2025-2035 | Growing Shifts Toward Targeted Therapies and Immunotherapy Over Traditional Methods

NVS

GlobeNewswire

23 days ago

Brain Cancer Market Research Report 2025-2035 | Growing Shifts Toward Targeted Therapies and Immunotherapy Over Traditional Methods

Gene and Cell Therapies Targeting CNS Disorders Market Research 2025-2035 | Technological Advancements in Precision Delivery Drive Growth, High Costs Challenging Accessibility

NVS

GlobeNewswire

23 days ago

Gene and Cell Therapies Targeting CNS Disorders Market Research 2025-2035 | Technological Advancements in Precision Delivery Drive Growth, High Costs Challenging Accessibility

Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer

NVS

GlobeNewswire

24 days ago

Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer

Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.

NVS

Barrons.com

a month ago

Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.

Novartis’ ribociclib approved in Canada for early breast cancer

NVS

Pharmaceutical Technology

a month ago

Novartis’ ribociclib approved in Canada for early breast cancer

NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth

NVS

PR Newswire

a month ago

NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth

NVS

CNW Group

a month ago

NYSE Content Advisory: Pre-Market update + Wall Street reopens after Juneteenth

FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention

NVS

Zacks

a month ago

FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

NVS

Zacks

a month ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

NVS

Zacks

a month ago

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

Gene Therapy Has Lost Support on Wall Street. There’s Still Hope for Big Cures.

NVS

Barrons.com

a month ago

Gene Therapy Has Lost Support on Wall Street. There’s Still Hope for Big Cures.

Trump administration weighs crackdown on pharma ads, Bloomberg says

NVS

TipRanks

a month ago

Trump administration weighs crackdown on pharma ads, Bloomberg says

Enliven Therapeutics, Inc. (ELVN) Backed by Goldman Sachs After Strong Trial Data

NVS

Insider Monkey

a month ago

Enliven Therapeutics, Inc. (ELVN) Backed by Goldman Sachs After Strong Trial Data

NVS

MT Newswires

a month ago

Market Chatter: Trump Administration to Consider Pharma Advertising Crackdown

Maxion Therapeutics Appoints Dr. Stefan Härtle as Chief Development Officer

NVS

GlobeNewswire

a month ago

Maxion Therapeutics Appoints Dr. Stefan Härtle as Chief Development Officer

RHHBY to Advance Parkinson's Disease Drug to Late-Stage Development

NVS

Zacks

a month ago

RHHBY to Advance Parkinson's Disease Drug to Late-Stage Development

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

NVS

Zacks

a month ago

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

Buy These 5 Low-Leverage Stocks Amid Fresh Iran-Israel War

NVS

Zacks

a month ago

Buy These 5 Low-Leverage Stocks Amid Fresh Iran-Israel War

Berenberg Bank Maintains a Hold Rating on Novartis (NVS)

NVS

Insider Monkey

a month ago

Berenberg Bank Maintains a Hold Rating on Novartis (NVS)

Senators to propose ban on drug ads to consumers, WSJ reports

NVS

TipRanks

a month ago

Senators to propose ban on drug ads to consumers, WSJ reports

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?

NVS

Zacks

a month ago

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?

NVS

Clinical Trials Arena

a month ago

Novartis reports positive results from Phase IIIB study of iptacopan for PNH

NVS

Morningstar Research

a month ago

Analyst Report: Novartis AG

NVS

MT Newswires

a month ago

Novartis Reports 'Significant' Improvements in Study of Fabhalta to Treat PNH

Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH

NVS

GlobeNewswire

a month ago

Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

NVS

TipRanks

a month ago

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

Top Cancer Stocks to Supercharge Your 2025 Portfolio

NVS

Zacks

a month ago

Top Cancer Stocks to Supercharge Your 2025 Portfolio

The former Wall Street analyst shaping Novartis’ big-picture strategy

NVS

Pharma Voice

a month ago

The former Wall Street analyst shaping Novartis’ big-picture strategy

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

NVS

Zacks

a month ago

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?

NVS

Zacks

a month ago

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?

Acquisitions, Licensing Deals Take Centerstage in Pharma/Biotech Space

NVS

Zacks

a month ago

Acquisitions, Licensing Deals Take Centerstage in Pharma/Biotech Space

NVS

Zacks

a month ago

Novartis (NVS) Could Be a Great Choice

2 Dividend Growth Stocks to Buy and Hold Forever

NVS

Motley Fool

a month ago

2 Dividend Growth Stocks to Buy and Hold Forever

Novartis reports topline outcomes from trial of Pluvicto for prostate cancer

NVS

Clinical Trials Arena

a month ago

Novartis reports topline outcomes from trial of Pluvicto for prostate cancer

ASCO25: Novartis hopes Scemblix becomes new standard for CML-CP

NVS

Clinical Trials Arena

a month ago

ASCO25: Novartis hopes Scemblix becomes new standard for CML-CP

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

NVS

Zacks

a month ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

NVS

Zacks

a month ago

Latest Novartis AG (NVS) News on July 17, 2025

Share on Social Networks: